Acadian Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,280
| Closed | -$415K | – | 1914 |
|
|
2024
Q3 | $415K | Buy |
+2,280
| New | +$415K | ﹤0.01% | 1129 |
|
|
2020
Q1 | – | Sell |
-5,032
| Closed | -$279K | – | 1859 |
|
|
2019
Q4 | $279K | Sell |
5,032
-7,921
| -61% | -$439K | ﹤0.01% | 1212 |
|
|
2019
Q3 | $450K | Sell |
12,953
-19,737
| -60% | -$686K | ﹤0.01% | 1112 |
|
|
2019
Q2 | $1.32M | Buy |
32,690
+12,953
| +66% | +$522K | 0.01% | 733 |
|
|
2019
Q1 | $649K | Sell |
19,737
-821
| -4% | -$27K | ﹤0.01% | 1032 |
|
|
2018
Q4 | $427K | Hold |
20,558
| – | – | ﹤0.01% | 944 |
|
|
2018
Q3 | $361K | Buy |
20,558
+8,356
| +68% | +$147K | ﹤0.01% | 956 |
|
|
2018
Q2 | $182K | Buy |
12,202
+10,331
| +552% | +$154K | ﹤0.01% | 1107 |
|
|
2018
Q1 | $19K | Buy |
+1,871
| New | +$19K | ﹤0.01% | 1498 |
|